
Evotech screens cancer candidates for Dewpoint Therapeutics
With this partnership, the Hamburg-based screening specialists have landed a really big deal Dewpint Therapeutics, the just four-year-old spin-off...

Scotland boosts bio-based manufacturing with £75m fund
Scottish Enterprise and Innovate UK will deliver the Launchpad programme, designed to focus on Scotland’s strengths in the sector. The packages,...

Study links TCM with effects on protein networks
The framework, validated with hospital patient data, is among the first to provide a scientific foundation to evaluate the therapeutic efficacy of...

Pierre Fabre Laboratories acquires Vertical Bio
The acquisition of Vertical Bio AG for an undisclosed amount of money allows Pierre Fabre Laboratories to...

Roche acquires Telavant Holdings to win TLA1 race
The takeover of Telavant, a 75:25 jont-venture of Roivant Sciences and the US pharmaceutical group Pfizer, however, may cost Roche up to US-$7.25bn....

Radiotherapy R&D partnership
French-US company Orano Med is developing Lead-212 (212Pb) Targeted Alpha Therapy, which combines the ability of biological molecules such as...

BioNtech reports Car-T/mRNA booster study results at ESMO
Testing different dose levels of its adoptive cell therapy BNT.221-01, a combination of Claudin 6 (CLDN6)-targeted Car-T cells (derived from...